Table of Content

Table of Contents

Global Pulmonary Drugs Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Pulmonary Drugs Market by Value
2.2.1 Global Pulmonary Drugs Revenue by Type
2.2.2 Global Pulmonary Drugs Market by Value (%)
2.3 Global Pulmonary Drugs Market by Production
2.3.1 Global Pulmonary Drugs Production by Type
2.3.2 Global Pulmonary Drugs Market by Production (%)

3. The Major Driver of Pulmonary Drugs Industry
3.1 Historical & Forecast Global Pulmonary Drugs Demand
3.2 Largest Application for Pulmonary Drugs (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Pulmonary Drugs Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Pulmonary Drugs Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Pulmonary Drugs Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Pulmonary Drugs Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Pulmonary Drugs Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Pulmonary Drugs Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Pulmonary Drugs Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Pulmonary Drugs Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Pulmonary Drugs Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Pulmonary Drugs Average Price Trend
12.1 Market Price for Each Type of Pulmonary Drugs in US (2018-2022)
12.2 Market Price for Each Type of Pulmonary Drugs in Europe (2018-2022)
12.3 Market Price for Each Type of Pulmonary Drugs in China (2018-2022)
12.4 Market Price for Each Type of Pulmonary Drugs in Japan (2018-2022)
12.5 Market Price for Each Type of Pulmonary Drugs in India (2018-2022)
12.6 Market Price for Each Type of Pulmonary Drugs in Korea (2018-2022)
12.7 Market Price for Each Type of Pulmonary Drugs in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Pulmonary Drugs Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Pulmonary Drugs

14. Pulmonary Drugs Competitive Landscape
14.1 Sanofi SA
14.1.1 Sanofi SA Company Profiles
14.1.2 Sanofi SA Product Introduction
14.1.3 Sanofi SA Pulmonary Drugs Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Meda Pharmaceuticals
14.2.1 Meda Pharmaceuticals Company Profiles
14.2.2 Meda Pharmaceuticals Product Introduction
14.2.3 Meda Pharmaceuticals Pulmonary Drugs Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Circassia Pharmaceuticals Plc.
14.3.1 Circassia Pharmaceuticals Plc. Company Profiles
14.3.2 Circassia Pharmaceuticals Plc. Product Introduction
14.3.3 Circassia Pharmaceuticals Plc. Pulmonary Drugs Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 AstraZeneca Plc.
14.4.1 AstraZeneca Plc. Company Profiles
14.4.2 AstraZeneca Plc. Product Introduction
14.4.3 AstraZeneca Plc. Pulmonary Drugs Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 GlaxoSmithKline Plc.
14.5.1 GlaxoSmithKline Plc. Company Profiles
14.5.2 GlaxoSmithKline Plc. Product Introduction
14.5.3 GlaxoSmithKline Plc. Pulmonary Drugs Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Mallinckrodt Pharmaceuticals Plc.
14.6.1 Mallinckrodt Pharmaceuticals Plc. Company Profiles
14.6.2 Mallinckrodt Pharmaceuticals Plc. Product Introduction
14.6.3 Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Cheisi Farmaceutici S.p.A
14.7.1 Cheisi Farmaceutici S.p.A Company Profiles
14.7.2 Cheisi Farmaceutici S.p.A Product Introduction
14.7.3 Cheisi Farmaceutici S.p.A Pulmonary Drugs Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Zambon Company S.p.A
14.8.1 Zambon Company S.p.A Company Profiles
14.8.2 Zambon Company S.p.A Product Introduction
14.8.3 Zambon Company S.p.A Pulmonary Drugs Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Alaxia SAS
14.9.1 Alaxia SAS Company Profiles
14.9.2 Alaxia SAS Product Introduction
14.9.3 Alaxia SAS Pulmonary Drugs Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Merck Sharp & Dohme Limited
14.10.1 Merck Sharp & Dohme Limited Company Profiles
14.10.2 Merck Sharp & Dohme Limited Product Introduction
14.10.3 Merck Sharp & Dohme Limited Pulmonary Drugs Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
15. Conclusion
16. Methodology and Data Source

List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Pulmonary Drugs Industry (Volume)
Figure 2. Pulmonary Drugs Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Pulmonary Drugs Revenue in 2022
Figure 5. US Pulmonary Drugs Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Pulmonary Drugs Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Pulmonary Drugs Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Pulmonary Drugs Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Pulmonary Drugs Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Pulmonary Drugs Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Pulmonary Drugs Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Pulmonary Drugs Revenue, by Type (Million USD) (2018-2028)
Table 4. Pulmonary Drugs Production, by Type (K Unit) (2018-2028)
Table 5. Pulmonary Drugs Demand (K Unit) by Application (2018-2028)
Table 6. Pulmonary Drugs Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Pulmonary Drugs Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Pulmonary Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Pulmonary Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Pulmonary Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Pulmonary Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Pulmonary Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Pulmonary Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Pulmonary Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Pulmonary Drugs in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Pulmonary Drugs in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Pulmonary Drugs in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Pulmonary Drugs in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Pulmonary Drugs in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Pulmonary Drugs in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Pulmonary Drugs in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Sanofi SA Profiles
Table 61. Sanofi SA Pulmonary Drugs Product Introduction
Table 62. Sanofi SA Pulmonary Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Sanofi SA Strategic initiatives
Table 64. Meda Pharmaceuticals Profiles
Table 65. Meda Pharmaceuticals Pulmonary Drugs Product Introduction
Table 66. Meda Pharmaceuticals Pulmonary Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Meda Pharmaceuticals Strategic initiatives
Table 68. Circassia Pharmaceuticals Plc. Profiles
Table 69. Circassia Pharmaceuticals Plc. Pulmonary Drugs Product Introduction
Table 70. Circassia Pharmaceuticals Plc. Pulmonary Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Circassia Pharmaceuticals Plc. Strategic initiatives
Table 72. AstraZeneca Plc. Profiles
Table 73. AstraZeneca Plc. Pulmonary Drugs Product Introduction
Table 74. AstraZeneca Plc. Pulmonary Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. AstraZeneca Plc. Strategic initiatives
Table 76. GlaxoSmithKline Plc. Profiles
Table 77. GlaxoSmithKline Plc. Pulmonary Drugs Product Introduction
Table 78. GlaxoSmithKline Plc. Pulmonary Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. GlaxoSmithKline Plc. Strategic initiatives
Table 80. Mallinckrodt Pharmaceuticals Plc. Profiles
Table 81. Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Product Introduction
Table 82. Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Mallinckrodt Pharmaceuticals Plc. Strategic initiatives
Table 84. Cheisi Farmaceutici S.p.A Profiles
Table 85. Cheisi Farmaceutici S.p.A Pulmonary Drugs Product Introduction
Table 86. Cheisi Farmaceutici S.p.A Pulmonary Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. Cheisi Farmaceutici S.p.A Strategic initiatives
Table 88. Zambon Company S.p.A Profiles
Table 89. Zambon Company S.p.A Pulmonary Drugs Product Introduction
Table 90. Zambon Company S.p.A Pulmonary Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. Zambon Company S.p.A Strategic initiatives
Table 92. Alaxia SAS Profiles
Table 93. Alaxia SAS Pulmonary Drugs Product Introduction
Table 94. Alaxia SAS Pulmonary Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Alaxia SAS Strategic initiatives
Table 97. Merck Sharp & Dohme Limited Profiles
Table 98. Merck Sharp & Dohme Limited Pulmonary Drugs Product Introduction
Table 99. Merck Sharp & Dohme Limited Pulmonary Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Merck Sharp & Dohme Limited Strategic initiatives